Become the partner of choice for innovative Pharmaceutical- and Biotech companies to commercialize Specialty, Rare Disease- and Hospital products in Switzerland by providing:
Medvisis Switzerland AG selects pharmaceutical products for which there is a high Medical Need and that are endorsed by Key Opinion Leaders
Our Mission
Swissmedic is an independent registration authority and serves as reference for other markets
The Swiss Reimbursement price and conditions are used as reference price by other markets
Medvisis’ Switzerland AG outstanding KOL network is critical for KOL partnership, top-down product endorsement and ultimately commercialization success
Head Medical Affairs
(Product Registration)
Head Reimbursement & Pricing
Ownership: Privately owned by Medvisis Leadership team (Aktiengesellschaft); no 3rd party debt financing